Literature DB >> 33353871

Lyme Disease Pathogenesis.

Jenifer Coburn1, Brandon Garcia2, Linden T Hu3, Mollie W Jewett4, Peter Kraiczy5, Steven J Norris6, Jon Skare7.   

Abstract

Lyme disease Borrelia are obligately parasitic, tick- transmitted, invasive, persistent bacterial pathogens that cause disease in humans and non-reservoir vertebrates primarily through the induction of inflammation. During transmission from the infected tick, the bacteria undergo significant changes in gene expression, resulting in adaptation to the mammalian environment. The organisms multiply and spread locally and induce inflammatory responses that, in humans, result in clinical signs and symptoms. Borrelia virulence involves a multiplicity of mechanisms for dissemination and colonization of multiple tissues and evasion of host immune responses. Most of the tissue damage, which is seen in non-reservoir hosts, appears to result from host inflammatory reactions, despite the low numbers of bacteria in affected sites. This host response to the Lyme disease Borrelia can cause neurologic, cardiovascular, arthritic, and dermatologic manifestations during the disseminated and persistent stages of infection. The mechanisms by which a paucity of organisms (in comparison to many other infectious diseases) can cause varied and in some cases profound inflammation and symptoms remains mysterious but are the subjects of diverse ongoing investigations. In this review, we provide an overview of virulence mechanisms and determinants for which roles have been demonstrated in vivo, primarily in mouse models of infection.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33353871      PMCID: PMC8046170          DOI: 10.21775/cimb.042.473

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  406 in total

1.  Development of lyme arthritis in mice deficient in inducible nitric oxide synthase.

Authors:  C R Brown; S L Reiner
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

2.  Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals.

Authors:  John V McDowell; Kelley M Hovis; Hongming Zhang; Emily Tran; Justin Lankford; R T Marconi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Comparative proteome analysis of subcellular fractions from Borrelia burgdorferi by NEPHGE and IPG.

Authors:  Andrew J Nowalk; Christi Nolder; Dawn R Clifton; James A Carroll
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

4.  Outer Membrane Proteins BB0405 and BB0406 Are Immunogenic, but Only BB0405 Is Required for Borrelia burgdorferi Infection.

Authors:  Binu Shrestha; Melisha R Kenedy; Darrin R Akins
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

Review 5.  Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates.

Authors:  P Kraiczy; C Skerka; M Kirschfink; P F Zipfel; V Brade
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

6.  Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants.

Authors:  Philip E Stewart; Jessica Hoff; Elizabeth Fischer; Jonathan G Krum; Patricia A Rosa
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

7.  A mechanism of protein localization: the signal hypothesis and bacteria.

Authors:  S D Emr; M N Hall; T J Silhavy
Journal:  J Cell Biol       Date:  1980-09       Impact factor: 10.539

8.  Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity.

Authors:  Tao Lin; Lihui Gao; Chuhua Zhang; Evelyn Odeh; Mary B Jacobs; Loïc Coutte; George Chaconas; Mario T Philipp; Steven J Norris
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

9.  RpoS regulates essential virulence factors remaining to be identified in Borrelia burgdorferi.

Authors:  Qilong Xu; Yanlin Shi; Poonam Dadhwal; Fang Ting Liang
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectin.

Authors:  Robert A Gaultney; Tammy Gonzalez; Angela M Floden; Catherine A Brissette
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more
  12 in total

1.  Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments.

Authors:  Amber M Frye; Monir Ejemel; Lisa Cavacini; Yang Wang; Michael J Rudolph; Renjie Song; Nicholas J Mantis
Journal:  Infect Immun       Date:  2022-08-24       Impact factor: 3.609

2.  VlsE, the nexus for antigenic variation of the Lyme disease spirochete, also mediates early bacterial attachment to the host microvasculature under shear force.

Authors:  Xi Tan; Yi-Pin Lin; Michael J Pereira; Mildred Castellanos; Beth L Hahn; Phillip Anderson; Jenifer Coburn; John M Leong; George Chaconas
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

3.  Utilizing Two Borrelia bavariensis Isolates Naturally Lacking the PFam54 Gene Array To Elucidate the Roles of PFam54-Encoded Proteins.

Authors:  Robert E Rollins; Janna Wülbern; Florian Röttgerding; Tristan A Nowak; Sabrina Hepner; Volker Fingerle; Gabriele Margos; Yi-Pin Lin; Peter Kraiczy; Noémie S Becker
Journal:  Appl Environ Microbiol       Date:  2022-01-05       Impact factor: 5.005

4.  Borrelia miyamotoi FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions.

Authors:  Charles E Booth; Alexandra D Powell-Pierce; Jon T Skare; Brandon L Garcia
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

5.  Deletion of a Genetic Region of lp17 Affects Plasmid Copy Number in Borrelia burgdorferi.

Authors:  Jessica K Wong; Michael A Crowley; Troy Bankhead
Journal:  Front Cell Infect Microbiol       Date:  2022-04-12       Impact factor: 6.073

Review 6.  The evolving story of Borrelia burgdorferi sensu lato transmission in Europe.

Authors:  Antje Steinbrink; Katharina Brugger; Gabriele Margos; Peter Kraiczy; Sven Klimpel
Journal:  Parasitol Res       Date:  2022-02-05       Impact factor: 2.289

7.  Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.

Authors:  Michael J Pereira; Beau Wager; Ryan J Garrigues; Eva Gerlach; Joshua D Quinn; Alexander S Dowdell; Marcia S Osburne; Wolfram R Zückert; Peter Kraiczy; Brandon L Garcia; John M Leong
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-21       Impact factor: 12.779

8.  Lyme Disease: A Role for Coenzyme Q10 Supplementation?

Authors:  David Mantle; Nadia Turton; Iain P Hargreaves
Journal:  Antioxidants (Basel)       Date:  2022-03-30

Review 9.  Defensins as a promising class of tick antimicrobial peptides: a scoping review.

Authors:  Jiahui Wu; Xia Zhou; Qiaoqiao Chen; Zhiqiang Chen; Jinyu Zhang; Lele Yang; Yuxuan Sun; Guohui Wang; Jianfeng Dai; Tingting Feng
Journal:  Infect Dis Poverty       Date:  2022-06-20       Impact factor: 10.485

10.  Borrelia burgdorferi modulates the physical forces and immunity signaling in endothelial cells.

Authors:  Raúl Aparicio Yuste; Marie Muenkel; Konstantinos Axarlis; María J Gómez Benito; Annalena Reuss; Grace Blacker; Michal Caspi Tal; Peter Kraiczy; Effie E Bastounis
Journal:  iScience       Date:  2022-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.